Position in SKYE
as of Jun 30, 2026
· filed Sep 22, 2026
Position Value
$6,398
+$612 QoQ
Shares Held
9,229
-2.0% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 42 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. SKYE ranks #418 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in SKYE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,398 | 73,830 | Shares | Defined | 2026-09-22 | |
| 2026-03-31 | $5,786 | 75,326 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,058 | 75,326 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $37,003 | 75,326 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,850 | 66,700 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $73,520 | 369,914 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $132,480 | 374,504 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $173,117 | 354,205 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $331,417 | 331,004 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||